How DDH-LSD compares to LSD in the body
Treatments studied
Part of Mental health clinical trials.
This study compares a substance called DDH-LSD to LSD to understand how the body processes it. It may help people who are curious about the effects of these substances in a controlled research setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 65 years old
- You understand German well enough to follow instructions
- You are in good physical health with no chronic or serious medical conditions
- You have no current or past major mental health disorders
- You have used hallucinogens like LSD less than 20 times in your life and not at all in the last two months
- You are not pregnant, breastfeeding, or planning to become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how three different psychedelic substances affect your state of mind. The goal is to better understand these altered states, which may help develop future treatments.
This Phase 2 trial studies whether an LSD treatment approach, combined with study procedures, can help people with moderate-to-severe alcohol use disorder cut down or stop drinking. It may help reset patterns around cravings and drinking, but it also requires careful safety screening.
This Phase 2 study tests whether a supervised dose of LSD (or a placebo) can reduce cluster headache attacks. It’s for people whose cluster headaches respond to oxygen, and who can safely pause certain medications and substances around the dosing day.
This Phase 2 study tests how LSD may affect comfort and quality of life for people with advanced or end-stage life-limiting illness. It also checks whether the medicine is safe and can be given in a controlled way in palliative care settings.
This study tests a single dose of a fast-acting psychedelic called 5-MeO-DMT given through a vein. It is only for healthy volunteers who have no medical or mental health conditions and limited previous experience with hallucinogens.
This trial tests whether a very low dose of LSD, taken at specific times, can reduce symptoms of severe premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD). It aims to find a new treatment option for women who have not found relief from other approaches.
Hear when a new LSD Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.